Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Clinical Trials in Georgia

452 recruiting clinical trials across 15 cities in Georgia (GA). Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
452
Total Trials
452
Recruiting Now
15
Cities
20
Conditions

Recruiting Trials in Georgia

Clinical trial data sourced from ClinicalTrials.gov. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT00567073

Pompe Pregnancy Sub-Registry

This Sub-registry is a multicenter, international, longitudinal, observational, and voluntary program designed to track pregnancy outcomes for any pregnant woman enrolled in the...

Sponsor: Genzyme, a Sanofi CompanyEnrolling: 2020 locations
Glycogen Storage Disease Type II (GSD-II)Pompe Disease (Late-onset)Glycogenesis 2 Acid Maltase Deficiency
RECRUITINGNCT00756665

Prostate Active Surveillance Study

The Prostate Active Surveillance Study (PASS) is a research study for men who have chosen active surveillance as a management plan for their prostate cancer. Active surveillance...

Sponsor: University of WashingtonEnrolling: 300011 locations
Prostatic Neoplasms
RECRUITINGNCT00912041

BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

The purpose of this study is to obtain preliminary device safety information and demonstrate proof of principle (feasibility) of the ability of people with tetraplegia to control...

Sponsor: Leigh R. Hochberg, MD, PhD.Enrolling: 275 locations
TetraplegiaSpinal Cord InjuriesAmyotrophic Lateral Sclerosis+3
RECRUITINGNCT01209000

Nephrotic Syndrome Study Network

Minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), and Membranous nephropathy (MN), generate an enormous individual and societal financial burden, accounting...

Sponsor: University of MichiganEnrolling: 120020 locations
Minimal Change Disease (MCD)Membranous NephropathyGlomerulosclerosis, Focal Segmental
RECRUITINGPhase 1NCT01245179

Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

The goal of this clinical research study is to find out about the safety and effects of a drug called panobinostat when given to adults with sickle cell disease. Panobinostat is a...

Sponsor: Abdullah KutlarEnrolling: 181 location
Sickle Cell Disease
RECRUITINGNCT01401998

ARPKD Database Study

Hepato-renal fibrocystic diseases (HRFD) is a term developed that encompasses rare diseases such as Autosomal Recessive Polycystic Kidney Disease (ARPKD), and other diseases with...

Sponsor: Children's Hospital of PhiladelphiaEnrolling: 2006 locations
Hepato/Renal Fibrocystic DiseaseAutosomal Recessive Polycystic Kidney DiseaseJoubert Syndrome+7
RECRUITINGNCT01574053

Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

Enroll-HD is a longitudinal, observational, multinational study that integrates two former Huntington's disease (HD) registries-REGISTRY in Europe, and COHORT in North America and...

Sponsor: CHDI Foundation, Inc.Enrolling: 3500020 locations
Huntington's Disease
RECRUITINGNCT01627301

Sympathetic Overactivity in Post-traumatic Stress Disorder

Post-traumatic stress disorder (PTSD) is a highly prevalent anxiety disorder that is associated with an increased risk of cardiovascular (CV) disease and hypertension. One...

Sponsor: Emory UniversityEnrolling: 1201 location
Post-traumatic Stress DisorderPrehypertension
RECRUITINGNCT01659749

Educational, Social Support, and Nutritional Interventions and Their Cumulative Effect on Pregnancy Outcomes and...

The purpose of this project is to study the effectiveness of teaching teens and young women with Phenylketonuria (PKU) or Maple Syrup Urine Disease (MSUD) about their disease and...

Sponsor: Emory UniversityEnrolling: 2001 location
PregnancyPhenylketonuria
RECRUITINGNCT01772602

The National Amyotrophic Lateral Sclerosis Registry

The purpose of this registry is to (A) better describe the incidence and prevalence of Amyotrophic Lateral Sclerosis (ALS) in the United States;(B) examine appropriate factors,...

Sponsor: Centers for Disease Control and PreventionEnrolling: 300001 location
Amyotrophic Lateral Sclerosis
RECRUITINGPhase 3NCT01804686

A Long-term Extension Study of PCI-32765 (Ibrutinib)

The purpose of this study is to collect long-term safety and efficacy data for participants treated with ibrutinib and to provide ongoing access to ibrutinib for participants who...

Sponsor: Janssen Research & Development, LLCEnrolling: 70020 locations
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaMantle Cell Lymphoma+4
RECRUITINGNCT01904851

Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes

XLPAD is an observational study designed to evaluate the effectiveness and use of stent and non-stent based therapies among PAD patients. The study will create a registry that...

Sponsor: Baylor Research InstituteEnrolling: 1400020 locations
Peripheral Arterial Disease
RECRUITINGNCT01915511

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

The Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry started recruiting in 2014 with the objective of studying Idiopathic Pulmonary Fibrosis. In 2018, the...

Sponsor: Duke UniversityEnrolling: 300020 locations
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
RECRUITINGNCT02135705

LOWER: Lomitapide Observational Worldwide Evaluation Registry

This global product exposure registry is a multicentre, long-term, prospective, observational cohort study (exposure registry), designed to evaluate the long term safety and...

Sponsor: Amryt PharmaEnrolling: 30020 locations
Homozygous Familial Hypercholesterolemia
RECRUITINGPhase 1 / Phase 2NCT02140255

Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

The study will explore the effects of early intensive antiretroviral therapy (ART) with or without a broadly neutralizing antibody (bNAb) on achieving HIV remission (HIV RNA below...

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)Enrolling: 112020 locations
HIV Infection
RECRUITINGPhase 2 / Phase 3NCT02205762

LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis

The LCH-IV is an international, multicenter, prospective clinical study for pediatric Langerhans Cell Histiocytosis LCH (age \< 18 years).

Sponsor: North American Consortium for HistiocytosisEnrolling: 140020 locations
Langerhans Cell Histiocytosis
RECRUITINGNCT02432560

Safety and Durability of Sirolimus for Treatment of LAM

The MIDAS study aims to follow male and female LAM patients who are currently taking, have previously failed or been intolerant of, or may (at some time in the future) take mTOR...

Sponsor: University of CincinnatiEnrolling: 60020 locations
Lymphangioleiomyomatosis
RECRUITINGPhase 1 / Phase 2NCT02447874

Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

The purpose of this study is to determine whether giving extra arginine to patients with sickle cell disease seeking treatment for vaso-occlusive painful events (VOE) will...

Sponsor: Emory UniversityEnrolling: 212 locations
Sickle Cell Disease
RECRUITINGPhase 3NCT02735707

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform trial for community-acquired pneumonia. The purpose of this study is to evaluate the effect of a range of...

Sponsor: UMC UtrechtEnrolling: 2000020 locations
Community-acquired Pneumonia, Influenza, COVID-19
RECRUITINGNCT02815891

A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across...

TARGET-NASH is a longitudinal observational cohort study of patients being managed for NASH and related conditions across the entire spectrum NAFLD in usual clinical practice....

Sponsor: Target PharmaSolutions, INC.Enrolling: 1500020 locations
Nonalcoholic Fatty LiverNonalcoholic Steatohepatitis
RECRUITINGPhase 3NCT02901184

Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction

Heart failure with preserved ejection fraction (HFPEF) is common and deadly but without therapy. Inconclusive studies such as TOPCAT (Treatment of Preserved Cardiac Function Heart...

Sponsor: Uppsala UniversityEnrolling: 200020 locations
Heart Failure With Preserved Ejection Fraction
RECRUITINGPhase 4NCT02915198

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

This research will help us to learn if the medicine called metformin reduces the risk of death, heart attacks, and/or strokes in Veterans who have pre-diabetes and heart or blood...

Sponsor: VA Office of Research and DevelopmentEnrolling: 741020 locations
Prediabetic StateAtherosclerosisMetformin
RECRUITINGPhase 2NCT02932150

Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection

The goals of this clinical study are to compare the effectiveness, safety and tolerability of study drug, tenofovir alafenamide (TAF), versus placebo in teens and children with...

Sponsor: Gilead SciencesEnrolling: 15020 locations
Chronic Hepatitis B
RECRUITINGPhase 2NCT02947750

Neurovascular Transduction During Exercise in Chronic Kidney Disease

The purpose of this study is to find out why patients with chronic kidney disease (CKD) have poor exercise capacity and to explore what causes an increase in blood pressure during...

Sponsor: Emory UniversityEnrolling: 1503 locations
Renal Insufficiency, Chronic
RECRUITINGNCT03003299

PARTNER 3 Trial - Aortic Valve-in-Valve

This study will assess the safety and effectiveness of the SAPIEN 3/SAPIEN 3 Ultra transcatheter heart valve (THV) in patients with a failing aortic bioprosthetic valve.

Sponsor: Edwards LifesciencesEnrolling: 12520 locations
Aortic StenosisAortic Stenosis, Severe
RECRUITINGNCT03047369

The Myelin Disorders Biorepository Project

The Myelin Disorders Biorepository Project (MDBP) seeks to collect and analyze clinical data and biological samples from leukodystrophy patients worldwide to support ongoing and...

Sponsor: Children's Hospital of PhiladelphiaEnrolling: 1200020 locations
LeukodystrophyWhite Matter DiseaseLeukoencephalopathies+63
RECRUITINGNCT03151629

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

Our intent is to establish the International Registry to Improve Outcomes in Men with Advanced Prostate Cancer (IRONMAN) as a prospective, international cohort of minimum 5,000...

Sponsor: Prostate Cancer Clinical Trials ConsortiumEnrolling: 500020 locations
Prostate Cancer
RECRUITINGPhase 1NCT03178149

A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due...

Age-related macular degeneration (AMD) is an eye disease which causes people to lose their sharp central vision over time. Aging damages the macula, which is in the middle of the...

Sponsor: Astellas Institute for Regenerative MedicineEnrolling: 4219 locations
Age-Related Macular Degeneration
RECRUITINGPhase 2NCT03304821

Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease

Peripheral artery disease (PAD) is a disease in which plaque builds up in the arteries that carry blood to the head, organs, and limbs. PAD usually occurs in the arteries in the...

Sponsor: Emory UniversityEnrolling: 1761 location
Peripheral Artery Disease (PAD)
RECRUITINGPhase 2 / Phase 3NCT03373968

Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study

This is an open label, long-term safety, tolerability, and efficacy study of GIVINOSTAT in all DMD (Duchenne's muscular dystrophy) patients who have been previously treated in one...

Sponsor: ItalfarmacoEnrolling: 20620 locations
Duchenne Muscular Dystrophy

Showing 30 of 452 trials in Georgia. Search all trials

Browse Trials by State

Frequently Asked Questions

There are currently 452 clinical trials actively recruiting participants in Georgia. These span all phases from early-stage Phase 1 to late-stage Phase 3 trials, across 20+ conditions.

The top conditions with recruiting trials in Georgia include Schizophrenia, Sickle Cell Disease, Multiple Myeloma, Duchenne Muscular Dystrophy, Cystic Fibrosis. Each has multiple active trials across research centers in the state.

Major trial sites in Georgia include Atlanta, Augusta, Decatur, Marietta, Savannah. Most large academic medical centers and research hospitals serve as trial sites.

Review the trial listings on this page and check the eligibility criteria — we translate them into plain English. When you find a trial that fits, talk to your doctor about whether it's right for you, then contact the trial team directly using the information on the trial page.

Sources: ClinicalTrials.gov
Last updated:

Trial data sourced from the ClinicalTrials.gov API. Location data reflects registered trial sites. This site does not provide medical advice.